 |
 |
|
|
RESÚMENES ABRIL 2006 |
Other Neuropsychiatric Disorders
& General Information
(Haga un click en la
información del journal para acceder al resúmen)
Longitudinal course of depression symptoms
in multiple sclerosis
P A Arnett and J J Randolph
Journal of Neurology, Neurosurgery, and Psychiatry 2006;77:606-610
Ictal
symptoms of anxiety, avoidance behaviour, and
dissociation in patients with dissociative seizures
L H Goldstein and J D C Mellers
Journal of Neurology, Neurosurgery, and Psychiatry 2006;77:616-621
Vitamin B6 Versus Mianserin
and Placebo in Acute Neuroleptic-induced Akathisia: A Randomized, Double-blind, Controlled Study
Miodownik, Chanoch; Lerner, Vladimir;
Statsenko, Nikolay; Dwolatzky, Tzvi; Nemets, Boris; Berzak, Elina; Bergman, Joseph
Clinical Neuropharmacology. 29(2):68-72, March/April 2006
Safety of High-Dose Naltrexone
Treatment: Hepatic Transaminase Profiles Among
Outpatients
Kim, Suck Won; Grant, Jon E.;
Yoon, Gihyun; Williams, Kyle A.; Remmel,
Rory P
Clinical Neuropharmacology. 29(2):77-79, March/April 2006
Effect
of Personal and Cultural Beliefs on Medication Adherence in the Elderly
Chia, Lichun (Rebecca); Schlenk, Elizabeth A; Dunbar-Jacob, Jacqueline
Drugs & Aging. 23(3):191-202, 2006
A
Systematic Review of the Clinical and Cost-Effectiveness of Memantine
in Patients with Moderately Severe to Severe Alzheimer's Disease
Kirby, Joanna; Green, Colin; Loveman, Emma; Clegg, Andrew; Picot, Joanna; Takeda,
Andrea; Payne, Elizabeth
Drugs & Aging. 23(3):227-240, 2006
A
Pilot Study Evaluating the Efficacy and Safety of Rivastigmine
in Patients with Mixed Dementia
Potkin, Steven G; Alva, Gus; Gunay,
Ibrahim; Koumaras, Barbara;
Chen, Michael; Mirski, Dario
Drugs & Aging. 23(3):241-249, 2006
Assessing
Therapeutic Efficacy in a Progressive Disease: A Study of Donepezil
in Alzheimer's Disease
Johannsen, Peter; Salmon, Eric; Hampel,
Harald; Xu, Yikang; Richardson, Sharon; Qvitzau,
Suzanne; Schindler, Rachel; and the AWARE Study Group
CNS Drugs. 20(4):311-325, 2006
Mild
cognitive impairment
Serge Gauthier, Barry Reisberg,
Michael Zaudig, Ronald C Petersen, Karen Ritchie,
Karl Broich, Sylvie Belleville, Henry Brodaty, David Bennett, Howard Chertkow,
Jeffrey L Cummings, Mony de Leon, Howard Feldman,
Mary Ganguli, Harald Hampel, Philip Scheltens, Mary C
Tierney, Peter Whitehouse, Bengt Winblad
and on behalf of the participants of the International Psychogeriatric
Association Expert Conference on mild cognitive impairment
The Lancet.
Volume 367, Issue 9518, 15 April 2006-21 April 2006, Pages 1262-1270
Nonconvulsive
Seizures in Electroconvulsive Therapy: Further Evidence of Differential Neurophysiological Aspects of Bitemporal
Versus Bifrontal Electrode Placement
Teman, Paul T.; Perry, Candace Lynn; Ryan, Debra A.;
Rasmussen, Keith G
Journal of ECT. 22(1):46-48, March 2006
Tolerability and Safety of High Daily Doses of
Repetitive Transcranial Magnetic Stimulation in
Healthy Young Men
Anderson, Berry; Mishory, Alexander; Nahas, Ziad; Borckardt, Jeffrey J.;
Yamanaka, Kaori; Rastogi, Komal;
George, Mark S
Journal of ECT. 22(1):49-53, March 2006
A Double-blind Comparison of Galantamine
Hydrogen Bromide and Placebo in Adults With Attention-Deficit/Hyperactivity
Disorder: A Pilot Study
Biederman, Joseph; Mick, Eric; Faraone,
Stephen; Hammerness, Paul; Surman,
Craig; Harpold, Theresa; Dougherty, Meghan; Aleardi, Megan; Spencer, Thomas
Journal of Clinical
Psychopharmacology. 26(2):163-166,
April 2006
Psychiatric
side effects of interferon-β in multiple sclerosis
J.-L. Goeb,
C. Even, G. Nicolas, B. Gohier, F. Dubas and J.B. Garré
European Psychiatry. Volume 21, Issue 3, April 2006, Pages 186-193
Illness
behaviour in neurological inpatients with psychiatric
morbidity
Lefteris Lykouras, Maria Vassiliadou, Dora
Adrachta, Argyro Voulgari, Nikos Kalfakis and
Constantine R. Soldatos
European Psychiatry. Volume 21, Issue 3, April 2006, Pages 200-203
Prediction of Psychosis Onset in Alzheimer Disease: The Role of Cognitive Impairment, Depressive Symptoms, and Further Evidence for Psychosis Subtypes
Patricia A. Wilkosz, Sachiko Miyahara,
Oscar L. Lopez, Steven T. DeKosky, and Robert A.
Sweet
Am J Geriatr Psychiatry
14:352-360, April 2006
Donepezil
in patients with severe Alzheimer's disease: double-blind, parallel-group,
placebo-controlled study
ProfBengt Winblad,
Lena Kilander, Sture
Eriksson, Lennart Minthon, Stellan Båtsman, Anna-Lena Wetterholm, Catarina Jansson-Blixt, Anders Haglund and
for the Severe Alzheimer's Disease Study Group
The Lancet.
Volume 367, Issue 9516, 1 April 2006-7 April 2006, Pages 1057-1065
Prevalence of Dissociative
Disorders in Psychiatric Outpatients
Brad Foote, Yvette Smolin,
Margaret Kaplan, Michael E. Legatt, and Deborah Lipschitz
American Journal of Psychiatry 163:623-629, April 2006
The Prevalence and Correlates of Adult
ADHD in the
Ronald C. Kessler, Lenard Adler, Russell Barkley, Joseph Biederman, C. Keith Conners, Olga
Demler, Stephen V. Faraone,
Laurence L. Greenhill, Mary J. Howes, Kristina Secnik, Thomas Spencer, T. Bedirhan
Ustun, Ellen E. Walters, and Alan M. Zaslavsky
American Journal of
Psychiatry 163:716-723, April 2006
Somatoform disorders in DSM-IV: Mental or
physical disorders?
Richard
Sykes
Journal of Psychosomatic
Research.
Volume 60, Issue 4, April 2006, Pages 341-344
Bodily
symptoms: New approaches to classification
Michael
Sharpe, Richard Mayou and Jane Walker
Journal of Psychosomatic
Research.
Volume 60, Issue 4, April 2006, Pages 353-356
Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review)
O. Suchowersky, G. Gronseth, J. Perlmutter, S.
Reich, T. Zesiewicz, and W. J. Weiner
Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review)
R. Pahwa, S. A. Factor, K. E.
Lyons, W. G. Ondo, G. Gronseth,
H. Bronte-Stewart, M. Hallett, J. Miyasaki,
J. Stevens, and W. J. Weiner
Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review)
J. M. Miyasaki, K. Shannon, V. Voon, B. Ravina, G. Kleiner-Fisman, K. Anderson, L. M. Shulman,
G. Gronseth, and W. J. Weiner
Effects of atorvastatin
on higher functions
G. P. Parale, N. N. Baheti,
P. M. Kulkarni and N. V. Panchal
European
Journal of Clinical Pharmacology 2006; Volume 62, Number 4: 259 - 265
The Relationship between Biogenetic
Causal Explanations and Social Distance toward People with Mental Disorders:
Results from a Population Survey in
Sandra Dietrich, Herbert Matschinger,
Matthias C. Angermeyer
International Journal of
Social Psychiatry, Vol. 52, No. 2, 166-174 (2006)
A 12 to 24 weeks pilot study of sertraline treatment in obese women binge eaters
Paolo Leombruni, Andrea Pierò, Annalisa Brustolin, Valeria Mondelli, Maura
Levi, Stefania Campisi, Susanna Marozio, Giovanni Abbate-Daga, Secondo Fassino
Human
Psychopharmacology: Clinical and Experimental. Volume 21, Issue 3, Pages 181 -
188
Academic
psychiatry and the pharmaceutical industry
Thomas
A. Ban
A
Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with
Attention-Deficit/Hyperactivity Disorder
Joseph Biederman, Eric Mick, Craig Surman,
Robert Doyle, Paul Hammerness, Theresa Harpold, Stephanie Dunkel, Meghan
Dougherty, Megan Aleardi and Thomas Spencer
Biological Psychiatry. Volume 59, Issue 9, 1 May 2006, Pages 829-835
Toward
a Reliable Distinction Between Patients with Mild
Cognitive Impairment and Alzheimer-Type Dementia Versus Major Depression
Anke Post, Nibal
Ackl, Monika Rücker, Yvonne
Schreiber, Elisabeth B. Binder, Marcus Ising, Annette
Sonntag, Florian Holsboer and Osborne F.X. Almeida
Biological Psychiatry. Volume 59, Issue 9, 1 May 2006, Pages 858-862
CSF amyloid-ß-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
Mirko Bibl, Brit Mollenhauer,
Hermann Esselmann, Piotr Lewczuk, Hans-Wolfgang Klafki, Katrin Sparbier, Alexandr Smirnov, Lukas Cepek,
Claudia Trenkwalder, Eckart
Rüther, Johannes Kornhuber,
Markus Otto and Jens Wiltfang
Conversion disorder: towards a neurobiological
understanding
| |
Neuropsychiatric Disease and Treatment. 2006; Volume: 2 | Issue: 1: 13-20
Risk factors of future
suicide in suicide attempters – A comparison between suicides and matched
survivors
Cecilia Holmstrand, Anders Niméus, Lil Träskman-Bendz
Nordic Journal of Psychiatry. Volume 60, Number 02 / March 2006 :
162 - 167
The Serotonergic Hypothesis for
Depression in Parkinson's Disease: an Experimental
Approach
Albert F G Leentjens,
Bart Scholtissen, Fred W Vreeling
and Frans R J Verhey
Neuropsychopharmacology (2006) 31, 10091015.
A clinical genetic method to identify
mechanisms by which pain causes depression and anxiety
Molecular
Pain 2006, 2:14; 19 April 2006
Neurologic Soft Signs in Borderline Personality
Disorder
José
Manuel De la Fuente, Julio Bobes,
Coro Vizuete, Maria-Teresa Bascaran,
Ignacio Morlán, and Julien Mendlewicz
J Clin Psychiatry 2006;67:541-546
A Systematic Review of Modafinil: Potential Clinical Uses and Mechanisms of Action
Jacob S.
Ballon,
and David Feifel
J Clin Psychiatry 2006;67:554-566
A Randomized Double-Blind Trial of Paroxetine and/or Dextroamphetamine and Problem-Focused Therapy for Attention-Deficit/Hyperactivity Disorder in Adults
Margaret
Weiss, Lily Hechtman, and The
Adult ADHD Research Group
J Clin Psychiatry 2006;67:611-619
Efficacy of Ziprasidone Against Hostility in Schizophrenia: Post Hoc Analysis of Randomized, Open-Label Study Data
Leslie Citrome, Jan Volavka, Pal Czobor, Shlomo Brook,
J Clin Psychiatry 2006;67:638-642
Efficacy
of perospirone in the management of aggressive
behavior associated with dementia
Shinji
Sato, Katsuyoshi Mizukami, Kazuo Moro, Yoshiro Tanaka
and Takashi Asada